Transcribed
Europe Has the Science. Where’s the Biotech Investment? | Siegfried Bialojan
51:44
For 25 years, Dr. Siegfried Bialojan has watched German biotech ask the same question: why doesn't the money show up? He explains why Germany never built a venture capital culture, the Strüngmann bet on BioNTech that nobody else would take, and why German innovation keeps being acquired by foreign capital.
Dr. Siegfried Bialojan is the former Executive Director of the EY Life Sciences Center in…